DIRECT TARGETING OF THE FKBP52 COCHAPERONE FOR THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER

$496,562FY2017Department of the ArmyDOD

The University Of Texas At El Paso

Investigators